Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. State Referral Letter
  6. /
STATE REFERRAL LETTER
••July 6, 2017

FDA STATE_REFERRAL_LETTER - Unknown Company - July 06, 2017

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore this company
Record Details

This STATE REFERRAL LETTER record concerns null, with an inspection on July 6, 2017, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Inspection Date
July 6, 2017
Product Type
Drugs
Office
Division of Pharmaceutical Quality Operations I
People
  • Art O. Czabaniuk (Program Division Director)
  • Nicholas F. Lyons (Director of Compliance)
  • Russell K. Riley (Investigator)
  • Yashwant Amin
Open in Dashboard

ID · 165e4d34-c8ec-4945-b183-f311743c76d8

Violation Codes3
21 CFR 20.64(d)(3)21 CFR 20.88FD&C Act 503A(a)

Full citation text and observation details available on the Dashboard.

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.